Institutional investors purchased a net $3.1 million shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 59.09% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COATUE MANAGEMENT LLC Bought 2.6 Million shares of Moderna Inc
RENAISSANCE TECHNOLOGIES LLC Bought 2.0 Million shares of Moderna Inc
THÉLÈME PARTNERS LLP Bought 1.3 Million shares of Moderna Inc